The Chondroitin Sulfate Market is witnessing unprecedented demand, largely driven by the increasing prevalence of joint disorders and a growing awareness of health supplements. Market projections suggest that by 2035, the market will reach an estimated 1.75 billion USD, reflecting a compound annual growth rate (CAGR) of 4.01%. This anticipated growth underscores a broader shift towards...

North America holds a leading revenue share in the global chondroitin sulfate market. The region benefits from advanced pharmaceutical manufacturing, widespread insurance coverage for ophthalmic surgical procedures, and a strong culture of wellness and active lifestyle management among older demographics. Key players across the US and Canada are actively investing in multi-ingredient joint...